Burning Rock Biotech Limited: current liabilities
Current liabilities for Burning Rock Biotech Limited. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All Burning Rock Biotech Limited financial histories
What this measure means
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
Exact concept: us-gaap:LiabilitiesCurrent. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2019-12-31 to 2025-12-31. The SEC response was captured on 2026-09-21.
Coverage by original unit
- CNY: 2019-12-31 to 2025-12-31.
- USD: 2020-12-31 to 2025-12-31.
These are separate reported series. A newer period in one unit does not update another unit’s history or establish a currency conversion.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 246,978,000 | CNY | 2026-04-28 | 20-F · 0001193125-26-183377 |
| At date | 2024-12-31 | 266,299,000 | CNY | 2026-04-28 | 20-F · 0001193125-26-183377 |
| At date | 2023-12-31 | 263,364,000 | CNY | 2025-04-29 | 20-F · 0001193125-25-101753 |
| At date | 2022-12-31 | 411,451,000 | CNY | 2024-04-29 | 20-F · 0001193125-24-119655 |
| At date | 2021-12-31 | 372,184,000 | CNY | 2023-04-20 | 20-F · 0001193125-23-108289 |
| At date | 2020-12-31 | 241,533,000 | CNY | 2022-04-29 | 20-F · 0001193125-22-133522 |
| At date | 2019-12-31 | 164,442,000 | CNY | 2021-03-23 | 20-F · 0001193125-21-090543 |
| At date | 2025-12-31 | 35,318,000 | USD | 2026-04-28 | 20-F · 0001193125-26-183377 |
| At date | 2024-12-31 | 36,484,000 | USD | 2025-04-29 | 20-F · 0001193125-25-101753 |
| At date | 2023-12-31 | 37,095,000 | USD | 2024-04-29 | 20-F · 0001193125-24-119655 |
| At date | 2022-12-31 | 59,655,000 | USD | 2023-04-20 | 20-F · 0001193125-23-108289 |
| At date | 2021-12-31 | 58,406,000 | USD | 2022-04-29 | 20-F · 0001193125-22-133522 |
| At date | 2020-12-31 | 37,018,000 | USD | 2021-03-23 | 20-F · 0001193125-21-090543 |
Related financial histories
- Burning Rock Biotech Limited: total assets
- Burning Rock Biotech Limited: total liabilities
- Burning Rock Biotech Limited: stockholders equity
- Burning Rock Biotech Limited: cash and cash equivalents
- Burning Rock Biotech Limited: net income or loss
- Burning Rock Biotech Limited: operating cash flow
- Burning Rock Biotech Limited: capital expenditure payments
- Burning Rock Biotech Limited: revenue
- Burning Rock Biotech Limited: financing cash flow
- Burning Rock Biotech Limited: investing cash flow
- Burning Rock Biotech Limited: retained earnings or deficit
- Burning Rock Biotech Limited: income tax expense or benefit
- Burning Rock Biotech Limited: net property, plant and equipment
- Burning Rock Biotech Limited: share-based compensation expense
- Burning Rock Biotech Limited: operating income or loss
- Burning Rock Biotech Limited: current assets
- Burning Rock Biotech Limited: interest expense
- Burning Rock Biotech Limited: current accounts payable
- Burning Rock Biotech Limited: net current accounts receivable
- Burning Rock Biotech Limited: common-stock repurchase payments
- Burning Rock Biotech Limited: net inventory
- Burning Rock Biotech Limited: gross profit
- Burning Rock Biotech Limited: cost of revenue
- Burning Rock Biotech Limited: research and development expense
Inspect the source
- Entity
- Burning Rock Biotech Limited / CIK 0001792267
- Captured
- 2026-09-21T17:27:33.084Z
- SEC response SHA-256
53bf08cb2d2ba67ef540e2f571d89bad60c773f769c7c552cf738c18925cf975
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001792267.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))